TNF and systemic lupus erythematosus: It has also been reported that, despite levels of antibodies to ds-DNA and cardiolipin being increased, anti-TNF-α therapy did not exacerbate SLE itself but rather achieved a reduction in disease activity and relief of refractory arthritis, nephritis, etc. [17].